MULLERIAN-INHIBITING SUBSTANCE IS PRESENT IN EMBRYONIC TESTES OF DOGS WITH PERSISTENT MULLERIAN DUCT SYNDROME

被引:27
|
作者
MEYERSWALLEN, VN
LEE, MM
MANGANARO, TF
KURODA, T
MACLAUGHLIN, D
DONAHOE, PK
机构
[1] CORNELL UNIV,COLL VET MED,JA BAKER INST,ITHACA,NY 14853
[2] CORNELL UNIV,COLL VET MED,DEPT CLIN SCI,ITHACA,NY 14853
[3] MASSACHUSETTS GEN HOSP,DEPT PEDIAT SURG,BOSTON,MA 02114
[4] MASSACHUSETTS GEN HOSP,DEPT PEDIAT,BOSTON,MA 02114
关键词
D O I
10.1095/biolreprod48.6.1410
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Mullerian Inhibiting Substance (MIS) causes regression of the Mullerian ducts during a critical period in embryonic development in male mammals. In Persistent Mullerian Duct Syndrome (PMDS), an autosomal recessive trait in humans and dogs, the Mullerian ducts fail to regress in otherwise normal males. Previously we reported that PMDS-affected dogs produce bioactive testicular MIS postnatally. The purpose of the present study was to determine whether PMDS-affected canine embryos appropriately express MIS mRNA and protein during the critical period for Mullerian duct regression. Homozygous (PMDS-affected) and normal canine embryos were removed from timed pregnancies. Gonadal sex and the degree of Mullerian duct regression were determined from histologic sections. Positive immunohistochemical staining for MIS was found in testis sections of PMDS-affected and normal male embryos. A 1.8-kb MIS mRNA transcript was detected in testes of PMDS-affected males and normal male embryos and neonates. Furthermore, equal amounts of MIS mRNA transcript were detected in testes of PMDS-affected embryos and normal male littermates during the critical period for Mullerian duct regression. These data support a hypothesis of target organ resistance, such as an abnormality in the putative MIS receptor, as the etiology of the defect in this dog model.
引用
收藏
页码:1410 / 1418
页数:9
相关论文
共 50 条
  • [41] The management of the persistent Mullerian duct syndrome
    Shalaby, Mahmoud M.
    Kurkar, Adel
    Zarzour, Mohamed A.
    Faddan, Amr A.
    Khalil, Mahmoud
    Abdelhafez, Mohamed F.
    ARAB JOURNAL OF UROLOGY, 2014, 12 (03) : 239 - 244
  • [42] FAMILIAL PERSISTENT MULLERIAN DUCT SYNDROME
    BEHESHTI, M
    CHURCHILL, BM
    HARDY, BE
    BAILEY, JD
    WEKSBERG, R
    ROGAN, GF
    JOURNAL OF UROLOGY, 1984, 131 (05): : 968 - 969
  • [43] Persistent mullerian duct syndrome in a dog
    Szabo, Z.
    Moser, J.
    Vincenti, S.
    SCHWEIZER ARCHIV FUR TIERHEILKUNDE, 2023, 165 (03): : 189 - 192
  • [44] A Case of Persistent Mullerian Duct Syndrome
    Graham, U.
    McCracken, E.
    Mullan, K.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2012, 181 : S362 - S363
  • [45] FAMILIAL PERSISTENT MULLERIAN DUCT SYNDROME
    SLOAN, WR
    WALSH, PC
    JOURNAL OF UROLOGY, 1976, 115 (04): : 459 - 461
  • [46] FAILURE OF GUBERNACULAR DEVELOPMENT IN THE PERSISTENT MULLERIAN DUCT SYNDROME ALLOWS HERNIATION OF THE TESTES
    HUTSON, JM
    DAVIDSON, PM
    REECE, LA
    BAKER, ML
    ZHOU, BY
    PEDIATRIC SURGERY INTERNATIONAL, 1994, 9 (08) : 544 - 546
  • [47] PERSISTENT MULLERIAN DUCT SYNDROME IN A GOAT
    HAIBEL, GK
    ROJKO, JL
    VETERINARY PATHOLOGY, 1990, 27 (02) : 135 - 137
  • [48] PROGRAMMED CELL-DEATH IN MULLERIAN DUCT INDUCED BY MULLERIAN INHIBITING SUBSTANCE
    PRICE, JM
    DONAHOE, PK
    ITO, Y
    HENDREN, WH
    AMERICAN JOURNAL OF ANATOMY, 1977, 149 (03): : 353 - 376
  • [49] ANORCHIA AND PERSISTENT MULLERIAN DUCT - VARIANT OF EMBRYONIC TESTICULAR REGRESSION SYNDROME
    PEREZPALACIOS, G
    FAZ, R
    BENAVIDES, S
    MANRIQUE, JJ
    LARREA, F
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1978, 47 (04): : 812 - 817
  • [50] CLEAVAGE OF MULLERIAN-INHIBITING SUBSTANCE ACTIVATES ANTIPROLIFERATIVE EFFECTS IN-VIVO
    KURIAN, MS
    DELACUESTA, RS
    WANECK, GL
    MACLAUGHLIN, DT
    MANGANARO, TF
    DONAHOE, PK
    CLINICAL CANCER RESEARCH, 1995, 1 (03) : 343 - 349